Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

3 terminated/withdrawn out of 42 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
15(68.2%)
Phase 3
4(18.2%)
Phase 2
2(9.1%)
Phase 1
1(4.5%)
22Total
N/A(15)
Phase 3(4)
Phase 2(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (42)

Showing 20 of 42 trials
NCT01279096Phase 1Completed

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT07542990Phase 3Not Yet Recruiting

Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care

Role: collaborator

NCT02123940Phase 3Completed

Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy

Role: collaborator

NCT03671291Not ApplicableCompleted

Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV

Role: collaborator

NCT07277361Recruiting

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

Role: collaborator

NCT07213531Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Role: collaborator

NCT06869499Not ApplicableNot Yet Recruiting

Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease

Role: collaborator

NCT06524583Phase 2Recruiting

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Role: collaborator

NCT05193591Recruiting

Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)

Role: collaborator

NCT02855827Recruiting

Constitution of a Cohort for Monitoring Patients Candidating for Ovarian Tissue Autograft

Role: collaborator

NCT02846064Not ApplicableRecruiting

Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function

Role: collaborator

NCT06029166Not ApplicableNot Yet Recruiting

Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors

Role: collaborator

NCT04148703Not ApplicableUnknown

Cost-utility Analysis of the Follow-up of Exclusive Telemedicine Pacemakers, Compared to Conventional Pacemakers

Role: collaborator

NCT01922635Not ApplicableTerminated

Validation of Metrological Properties of Lymphoqol

Role: collaborator

NCT05149001Completed

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

Role: collaborator

NCT05131633Completed

Regional Anaesthesia in Intensive Care Unit

Role: collaborator

NCT05632289Not ApplicableUnknown

Osteopathic Manipulation in the Management of Pain Associated With Sickel Cell Disease

Role: collaborator

NCT05302115Unknown

S-ICD French Cohort Study (HONEST)

Role: collaborator

NCT01380028Phase 3Terminated

Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas

Role: collaborator

NCT04026594Not ApplicableUnknown

Mindfulness-based Therapy Versus Relaxation in Prevention of Burnout in Medical Students

Role: collaborator